PT1861405E - Método de diminuír a quantidade de cetonas insaturadas em alfa-beta numa composição de opiáceos - Google Patents

Método de diminuír a quantidade de cetonas insaturadas em alfa-beta numa composição de opiáceos Download PDF

Info

Publication number
PT1861405E
PT1861405E PT06707309T PT06707309T PT1861405E PT 1861405 E PT1861405 E PT 1861405E PT 06707309 T PT06707309 T PT 06707309T PT 06707309 T PT06707309 T PT 06707309T PT 1861405 E PT1861405 E PT 1861405E
Authority
PT
Portugal
Prior art keywords
beta
unsaturated ketones
reducing alpha
opioid compositions
reducing
Prior art date
Application number
PT06707309T
Other languages
English (en)
Inventor
Robert J Kupper
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of PT1861405E publication Critical patent/PT1861405E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
PT06707309T 2005-03-04 2006-02-27 Método de diminuír a quantidade de cetonas insaturadas em alfa-beta numa composição de opiáceos PT1861405E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65879105P 2005-03-04 2005-03-04

Publications (1)

Publication Number Publication Date
PT1861405E true PT1861405E (pt) 2009-07-27

Family

ID=36301669

Family Applications (2)

Application Number Title Priority Date Filing Date
PT09158939T PT2112153E (pt) 2005-03-04 2006-02-27 Método de diminuír a quantidade de cetonas insaturadas em alfa-beta em composições de opiáceos
PT06707309T PT1861405E (pt) 2005-03-04 2006-02-27 Método de diminuír a quantidade de cetonas insaturadas em alfa-beta numa composição de opiáceos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT09158939T PT2112153E (pt) 2005-03-04 2006-02-27 Método de diminuír a quantidade de cetonas insaturadas em alfa-beta em composições de opiáceos

Country Status (19)

Country Link
US (1) US7939543B2 (pt)
EP (2) EP1861405B1 (pt)
JP (1) JP5314894B2 (pt)
KR (1) KR100941761B1 (pt)
CN (1) CN101133062B (pt)
AT (2) ATE487722T1 (pt)
CA (1) CA2598774C (pt)
CY (2) CY1109262T1 (pt)
DE (2) DE602006018208D1 (pt)
DK (2) DK1861405T3 (pt)
ES (2) ES2355870T3 (pt)
HK (2) HK1111695A1 (pt)
HR (2) HRP20090387T1 (pt)
ME (2) ME01594B (pt)
PL (2) PL2112153T3 (pt)
PT (2) PT2112153E (pt)
RS (2) RS51568B (pt)
SI (2) SI2112153T1 (pt)
WO (1) WO2006094672A1 (pt)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
NZ545202A (en) * 2003-08-06 2010-03-26 Gruenenthal Chemie Abuse-proofed dosage form comprising opiods and a high molecular weight polyethylene oxide
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
TW201509943A (zh) 2004-03-30 2015-03-16 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
DE102004032049A1 (de) * 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
WO2007103105A2 (en) 2006-03-02 2007-09-13 Mallinckrodt Inc. Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
JP2010511725A (ja) 2006-12-04 2010-04-15 ノランコ・インコーポレーテツド オキシコドン塩基中の不純物を減少させる方法
CA2671518C (en) 2006-12-04 2016-06-07 Noramco, Inc. Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
AU2008241528B2 (en) * 2007-04-16 2013-07-04 Mallinckrodt Llc Novel opiate reduction utilizing catalytic hydrogen transfer reaction
FR2923484B1 (fr) * 2007-11-09 2012-11-09 Sanofi Aventis Procede de preparation de composes morphiniques
TWI454288B (zh) 2008-01-25 2014-10-01 Gruenenthal Chemie 藥物劑型
US8372432B2 (en) * 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
EP2262484B1 (en) * 2008-03-11 2013-01-23 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
PT2273983T (pt) 2008-05-09 2016-10-28 Gruenenthal Gmbh Processo para a preparação de uma formulação em pó intermediária e uma forma de dosagem sólida final sob utilização de uma etapa de congelamento por atomização
KR101747156B1 (ko) 2009-07-22 2017-06-27 그뤼넨탈 게엠베하 산화-안정화된 탬퍼-내성 용량형
RU2547555C2 (ru) * 2009-07-22 2015-04-10 Грюненталь Гмбх Экструдированная из горячего расплава фармацевтическая лекарственная форма
RU2012112552A (ru) * 2009-08-31 2013-10-10 Дипомед, Инк. Удерживаемые в желудке фармацевтические композиции для немедленного и продленного высвобождения ацетаминофена
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
EP2377866B1 (en) * 2010-03-23 2014-02-26 Siegfried AG Preparation of low impurity opiates in a continuous flow reactor
EP2580218B1 (en) 2010-06-11 2015-02-25 Rhodes Technologies Process for n-dealkylation of tertiary amines
EP2580201B1 (en) 2010-06-11 2017-08-02 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
EP2611426B1 (en) 2010-09-02 2014-06-25 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
EP2611425B1 (en) 2010-09-02 2014-07-02 Grünenthal GmbH Tamper resistant dosage form comprising an anionic polymer
US9050335B1 (en) 2011-05-17 2015-06-09 Mallinckrodt Llc Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
DK2736495T3 (da) 2011-07-29 2017-11-13 Gruenenthal Gmbh Misbrugsbestandig tablet som tilvejebringer øjeblikkelig frigivelse af lægemiddel
US20130028972A1 (en) 2011-07-29 2013-01-31 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
CA2864949A1 (en) 2012-02-28 2013-09-06 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
EA201401139A1 (ru) 2012-04-18 2015-03-31 Грюненталь Гмбх Устойчивая к разрушению и к сбросу дозы фармацевтическая лекарственная форма
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
EP2970320B1 (en) * 2013-03-15 2020-10-28 Johnson Matthey Public Limited Company Morphine sulfate methanolic solvate, processes for making same and related compositions and methods for treating pain
JP6466417B2 (ja) 2013-05-29 2019-02-06 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
KR20160031526A (ko) 2013-07-12 2016-03-22 그뤼넨탈 게엠베하 에틸렌-비닐 아세테이트 중합체를 함유하는 템퍼 내성 투여형
CN105934241B (zh) 2013-11-26 2020-06-05 格吕伦塔尔有限公司 通过低温研磨制备粉末状药物组合物
US10227354B2 (en) 2013-12-18 2019-03-12 Cody Laboratories, Inc. Conversion of oxycodone base to oxycodone hydrochloride
US9062062B1 (en) 2013-12-18 2015-06-23 Cody Laboratories, Inc. Synthesis of oxycodone hydrochloride
US8846923B1 (en) 2013-12-18 2014-09-30 Cody Laboratories, Inc. Preparation of 14-hydroxycodeinone sulfate
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
MX2016015417A (es) 2014-05-26 2017-02-22 Gruenenthal Gmbh Multiparticulas protegidas contra vertido de dosis etanolico.
CA2954600A1 (en) 2014-07-09 2016-01-14 Rhodes Technologies Reduction of alpha, beta-unsaturated ketone levels in morphinan derivative compositions
EP3285745A1 (en) 2015-04-24 2018-02-28 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3812312A (en) 1971-11-15 1974-05-21 Chrysler Corp Impact velocity sensor switch with linearly movable controller
US5869669A (en) 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
GB9713703D0 (en) 1997-06-30 1997-09-03 Johnson Matthey Plc Preparation of opiates
US6177567B1 (en) 1999-10-15 2001-01-23 Boehringer Ingelheim Chemicals, Inc. Method for preparing oxycodone
TW201509943A (zh) * 2004-03-30 2015-03-16 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝

Also Published As

Publication number Publication date
CY1111241T1 (el) 2015-06-11
RS51131B (sr) 2010-10-31
CA2598774C (en) 2010-12-21
CY1109262T1 (el) 2014-07-02
PT2112153E (pt) 2010-12-17
CN101133062B (zh) 2014-08-06
HRP20110078T1 (hr) 2011-03-31
WO2006094672A1 (en) 2006-09-14
HK1135107A1 (en) 2010-05-28
ME01184B (me) 2013-03-20
EP1861405A1 (en) 2007-12-05
PL1861405T3 (pl) 2009-10-30
ES2355870T3 (es) 2011-03-31
SI2112153T1 (sl) 2011-02-28
DE602006006558D1 (de) 2009-06-10
EP1861405B1 (en) 2009-04-29
DE602006018208D1 (de) 2010-12-23
EP2112153A1 (en) 2009-10-28
DK1861405T3 (da) 2009-07-20
ME01594B (me) 2014-09-20
KR100941761B1 (ko) 2010-02-11
JP5314894B2 (ja) 2013-10-16
ATE430153T1 (de) 2009-05-15
DK2112153T3 (da) 2011-02-14
KR20070108931A (ko) 2007-11-13
CA2598774A1 (en) 2006-09-14
US7939543B2 (en) 2011-05-10
RS51568B (en) 2011-08-31
SI1861405T1 (sl) 2009-10-31
PL2112153T3 (pl) 2011-04-29
JP2008531626A (ja) 2008-08-14
ATE487722T1 (de) 2010-11-15
HK1111695A1 (en) 2008-08-15
HRP20090387T1 (en) 2009-08-31
US20080132702A1 (en) 2008-06-05
EP2112153B1 (en) 2010-11-10
ES2326491T3 (es) 2009-10-13
CN101133062A (zh) 2008-02-27

Similar Documents

Publication Publication Date Title
HK1135107A1 (en) Method of reducing alpha, beta- unsaturated ketones in opioid compositions
MX2008010921A (es) Procesos para preparar productos de morfinan-6-ona con bajos niveles de compuestos de cetona alfa, beta-insaturados.
MY155418A (en) Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
TW200736256A (en) Process for the preparation of substituted heterocycles
WO2008013840A3 (en) Erastin analogs and uses thereof
NZ602862A (en) Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
WO2011060304A3 (en) Oxygen scavengers, compositions comprising the scavengers, and artcles made from the compositions
EP1783166A4 (en) RESIN COMPOSITION AND PROCESS FOR PRODUCING LAMINATE USING THE SAME
WO2009117676A3 (en) Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase
MY155478A (en) Process for the regioselective preparation of 1-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivatives
MX2010004195A (es) Trans-clomifeno para el sindrome metabolico.
WO2011060297A3 (en) Oxygen scavengers, composition comprising the scavengers, and articles made from the compositions
IL227565A (en) Salts of hexahydropananthridine preserved in position 5 of the heterocyclic group and pharmaceutical preparations containing them
DK2044067T3 (da) Fremgangsmåde til fremstilling af 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octanbromid
MX2011008885A (es) Composiciones, sintesis y metodos para usar derivados de arilpiperazina.
UA96994C2 (ru) Производные 7-алкинил-1,8-нафтиридонов, способ их получения и их применения в терапии
ATE524427T1 (de) Verfahren zur herstellung von 3-methyl-1,5- pentandiol
WO2009154993A8 (en) Compositions, synthesis, and methods of using piperazine based antipsychotic agents
ATE452117T1 (de) Verfahren zur herstellung von cyclischen ketonen
DK2038341T3 (da) Sammensætning med en polymer og en oxidationskatalysator
ATE511760T1 (de) Nuss-stückchen enthaltendes kaugummi
EA200870236A1 (ru) Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе
WO2008011161A3 (en) Dermal anesthetic compounds
MX2009003200A (es) Procedimiento para la preparacion de pradofloxacino.
WO2008080120A3 (en) 3-amino chromane derivatives